This page was last updated on 2/4/2022. Please check back frequently for updates.

How should care for patients with cancer types (e.g. breast cancer, lung cancer) be affected?

This section provides links to disease-specific information that has been released by other organizations.

Breast cancer

  • The American Society of Breast Surgeons has published information on triage, prioritization, appropriate care, and reentry into therapy for patients with breast cancer available on its COVID-19 resource center.
  • The American College of Surgeons has published information on the triage of patients with breast cancer for surgery. 
  • An international multi-organizational group has also published recommendations on the same topic (Curigliano et al, Breast)
  • The European Society of Medical Oncology (ESMO) has published information on care for patients with breast cancer (de Azambuja et al, ESMO Open)

Gastrointestinal cancers​

Genitourinary cancers

  • Canadian recommendations on prioritizing systemic therapy in patients with genitourinary malignancies has been published.  (Lalani et al, Can Urol Assoc J)
  • An editorial in European Urology has presented considerations for the triage of patients for urological surgery, including patients with genitourinary malignancies (Stresland et al, Eur Urol
  • The Canadian Urologic Oncology Group and the Canadian Urological Association have published guidelines for care of patients with prostate cancer (Kokorovic et al, Can Urol Assoc J)
  • The German Cancer Society has published information on systemic therapy for patients with advanced/metastatic renal cell carcinoma during the pandemic (Ivanyi et al, J Cancer Res Clin Oncol).

Gynecological cancers

  • The editors of the International Journal of Gynecological Cancer have published information for the management of patients with those cancers. (Ramirez et al, Int J Gynecol Cancer)
  • The National College of French Gynecologists and Obstetricians have published recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic (Akladios et al, J Gynecol Obstet Hum Reprod
  • An American multi-institutional group has published recommendations for anti-cancer therapy and surveillance for recurrence of patients with gynecological cancers (Pothuri et al, Gynecol Oncol)
  • ESMO has published information on the management of patients with gynecological malignancies (Columbo et al, ESMO Open)

Head and neck cancer

  • The French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL) and French Society of Head and Neck Carcinology (SFCCF) have published consensus recommendations on the management of patients requiring head and neck cancer surgery (Fakhry et al, Eur Ann Otorhinolaryngol Head Neck Dis). Similar recommendations have been published by the Canadian Association of Head and Neck Surgical Oncology (O’Connell et al, J Otolaryngol Head Neck Surg)
  • The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium has published detailed cancer-site specific recommendations for triage for head and neck cancer surgery (Head et al, Head Neck)

Hematological malignancy

  • The American Society of Hematology has released information related to several different malignancies.
  • Multiple Myeloma
    • An international group of authors has published recommendations on the care of older patients with multiple myeloma (Mian et al, J Geriatr Oncol)
    • A group from the Mayo Clinic has published recommendations regarding the management of patients with multiple myeloma (Al Saleh, Acta Haematol)
  • An Australia/New Zealand consensus statement on care for patients with lymphoma, chronic lymphocytic leukemia and myeloma is available (Di Ciaccio et al, Intern Med J)
  • The European Hematology Association and ESMO have published recommendations on the management of malignant lymphoma (Dreyling et al, Hemasphere)

Hepatocellular carcinoma

  • The International Liver Cancer Association (ILCA) has released information related to are of patients with hepatocellular carcinoma. The Asia-Pacific Association for the Study of the Liver (APASL) has released similar information (Shiina et al, Hepatol Int)

Lung cancer


  • The American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Tumor Section and the Society for Neuro-Oncology (SNO) have published general information on care of patients with brain tumors and brain metastases (Ramakrishna et al, J Neurooncol)
  • Information specific to the management of patients with glioma has been published by two international multi-disciplinary groups (Mohile et al, Neuro OncolBernhardt et al Neuro Oncol)


  • The Sarcoma European and Latin American Network has published information on prioritization of care for patients with various forms of sarcoma (Martin Broto et al, Oncologist)

Skin cancer and cutaneous lymphoma


Multiple cancer types

  • The Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) have published information on care for multiple cancer types (Giesen et al, Eur J Cancer)
  • ESMO has published information on general supportive care of all cancer patients (Aapro et al, ESMO Open)

Subpopulation-specific Information: Is there any information specific to subpopulations of patients with cancer?

Pediatric Patients

  • A multi-organizational group has published recommendations on care for pediatric patients (Sullivan et al, Pediatr Blood Cancer)
  • The International Late Effects of Childhood Cancer Guideline Harmonization Group has published information on risk factors and care for survivors of childhood, adolescent, and young adult onset cancer (Verbruggen et al, Pediatr Blood Cancer)


Answers to questions about COVID-19 published herein are provided by the American Society of Clinical Oncology, Inc. (“ASCO”) for voluntary, informational use by providers in the rapidly evolving novel coronavirus crisis. This information does not constitute medical or legal advice, is not intended for use in the diagnosis or treatment of individual conditions, does not endorse products or therapies, recommend or mandate any particular course of medical care, and is not a statement of the standard of care. New evidence may emerge between the time information is developed and when it is published or read. The information is not comprehensive or continually updated. This information is not intended to substitute for the independent professional judgment of the treating provider in the context of treating the individual patient. ASCO provides this information on an “as is” basis, and makes no warranty, express or implied, regarding the information. ASCO specifically disclaims any warranties of merchantability or fitness for a particular use or purpose. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of this information or for any errors or omissions. Use of the information is subject to the complete ASCO website Terms of Use